1. Anty R, and Gual P. [Pathogenesis of non-alcoholic fatty liver disease]. Presse Med. 2019;48(12):1468-1483. Http://dx.doi.org/10.1016/j.lpm.2019.09.051
2. Colca J. NASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease: multiple chronic conditions and a potential treatment at the metabolic root. Expert Opin Investig Drugs. 2020;29(2):191-196. Http://dx.doi.org/10.1080/13543784.2020.1715940
3. Kim YN, Shin JH, Kyeong DS, Cho SY, Kim MY, Lim HJ, et al. Ahnak deficiency attenuates high-fat diet-induced fatty liver in mice through FGF21 induction. Exp Mol Med. 2021;53(3):468-482. Http://dx.doi.org/10.1038/s12276-021-00573-3
4. Liu XL, Ming YN, Zhang JY, Chen XY, Zeng MD, and Mao YM. Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes. Exp Mol Med. 2017;49(1):e283. Http://dx.doi.org/10.1038/emm.2016.123
5. Zhang YK, Wu KC, Liu J, and Klaassen CD. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. Toxicol Appl Pharmacol. 2012;264(3):305-314. Http://dx.doi.org/10.1016/j.taap.2012.09.014
6. Xu L, Nagata N, and Ota T. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. Int J Mol Sci. 2019;20(23)Http://dx.doi.org/10.3390/ijms20235920
7. Ramadori P, Drescher H, Erschfeld S, Schumacher F, Berger C, Fragoulis A, et al. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development. Free Radic Biol Med. 2016;91:114-126. Http://dx.doi.org/10.1016/j.freeradbiomed.2015.12.014
8. Codogno P, and Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005;12 Suppl 2:1509-1518. Http://dx.doi.org/10.1038/sj.cdd.4401751
9. Mialet-Perez J, and Vindis C. Autophagy in health and disease: focus on the cardiovascular system. Essays Biochem. 2017;61(6):721-732. Http://dx.doi.org/10.1042/ebc20170022
10. Huda N, Zou H, Yan S, Khambu B, and Yin XM. Analysis of Autophagy for Liver Pathogenesis. Methods Mol Biol. 2019;1880:481-489. Http://dx.doi.org/10.1007/978-1-4939-8873-0_30
11. Khambu B, Yan S, Huda N, Liu G, and Yin XM. Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease. Liver Res. 2018;2(3):112-119. Http://dx.doi.org/10.1016/j.livres.2018.09.004
12. Ren H, Wang D, Zhang L, Kang X, Li Y, Zhou X, et al. Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice. Aging (Albany NY). 2019;11(21):9461-9477. Http://dx.doi.org/10.18632/aging.102396
13. Zhou T, Chang L, Luo Y, Zhou Y, and Zhang J. Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. Redox Biol. 2019;21:101120. Http://dx.doi.org/10.1016/j.redox.2019.101120
14. Martinez-Lopez N, and Singh R. Autophagy and Lipid Droplets in the Liver. Annu Rev Nutr. 2015;35:215-237. Http://dx.doi.org/10.1146/annurev-nutr-071813-105336
15. Yang L, Li P, Fu S, Calay ES, and Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010;11(6):467-478. Http://dx.doi.org/10.1016/j.cmet.2010.04.005
16. Park HW, Park H, Semple IA, Jang I, Ro SH, Kim M, et al. Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers. Nat Commun. 2014;5:4834. Http://dx.doi.org/10.1038/ncomms5834
17. Ghosh S, Choudhury S, Chowdhury O, Mukherjee S, Das A, Sain A, et al. Inflammation-induced behavioral changes is driven by alterations in Nrf2-dependent apoptosis and autophagy in mouse hippocampus: Role of fluoxetine. Cell Signal. 2020;68:109521. Http://dx.doi.org/10.1016/j.cellsig.2019.109521
18. Yang M, Liang Z, Yang M, Jia Y, Yang G, He Y, et al. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism. Faseb j. 2019;33(9):10077-10088. Http://dx.doi.org/10.1096/fj.201802544RR
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550. Http://dx.doi.org/10.1073/pnas.0506580102
20. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. Http://dx.doi.org/10.1093/nar/gkv007
21. Huang da W, Sherman BT, and Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1-13. Http://dx.doi.org/10.1093/nar/gkn923
22. Fu J, Li C, Zhang G, Tong X, Zhang H, Ding J, et al. Crucial Roles of 5-HT and 5-HT2 Receptor in Diabetes-Related Lipid Accumulation and Pro-Inflammatory Cytokine Generation in Hepatocytes. Cell Physiol Biochem. 2018;48(6):2409-2428. Http://dx.doi.org/10.1159/000492656
23. Wang X, Zhang X, Chu ESH, Chen X, Kang W, Wu F, et al. Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis. Faseb j. 2018;32(1):37-51. Http://dx.doi.org/10.1096/fj.201601393R
24. Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170(3):548-563.e516. Http://dx.doi.org/10.1016/j.cell.2017.07.008
25. Zhang C, Luo X, Chen J, Zhou B, Yang M, Liu R, et al. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. Diabetes. 2019;68(10):1902-1914. Http://dx.doi.org/10.2337/db18-1055
26. Zhou M, Xu X, Wang H, Yang G, Yang M, Zhao X, et al. Effect of central JAZF1 on glucose production is regulated by the PI3K-Akt-AMPK pathway. Faseb j. 2020;34(5):7058-7074. Http://dx.doi.org/10.1096/fj.201901836RR
27. Cui A, Fan H, Zhang Y, Zhang Y, Niu D, Liu S, et al. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia. J Clin Invest. 2019;129(6):2266-2278. Http://dx.doi.org/10.1172/jci66062
28. Zhang X, Wu WK, Xu W, Man K, Wang X, Han J, et al. C-X-C Motif Chemokine 10 Impairs Autophagy and Autolysosome Formation in Non-alcoholic Steatohepatitis. Theranostics. 2017;7(11):2822-2836. Http://dx.doi.org/10.7150/thno.19068
29. Jain A, Lamark T, Sjøttem E, Larsen KB, Awuh JA, Øvervatn A, et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem. 2010;285(29):22576-22591. Http://dx.doi.org/10.1074/jbc.M110.118976
30. Babuta M, Furi I, Bala S, Bukong TN, Lowe P, Catalano D, et al. Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro-RNA 155 in Alcoholic Liver Disease. Hepatology. 2019;70(6):2123-2141. Http://dx.doi.org/10.1002/hep.30766
31. Pajares M, Jiménez-Moreno N, García-Yagüe Á J, Escoll M, de Ceballos ML, Van Leuven F, et al. Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy. 2016;12(10):1902-1916. Http://dx.doi.org/10.1080/15548627.2016.1208889
32. Friedman SL, Neuschwander-Tetri BA, Rinella M, and Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908-922. Http://dx.doi.org/10.1038/s41591-018-0104-9
33. Li L, Fu J, Liu D, Sun J, Hou Y, Chen C, et al. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression. Redox Biol. 2020;30:101412. Http://dx.doi.org/10.1016/j.redox.2019.101412
34. Meakin PJ, Chowdhry S, Sharma RS, Ashford FB, Walsh SV, McCrimmon RJ, et al. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol Cell Biol. 2014;34(17):3305-3320. Http://dx.doi.org/10.1128/mcb.00677-14
35. Liu Z, Dou W, Ni Z, Wen Q, Zhang R, Qin M, et al. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet. Mol Med Rep. 2016;14(2):1323-1331. Http://dx.doi.org/10.3892/mmr.2016.5393
36. Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, et al. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur J Pharmacol. 2009;620(1-3):138-144. Http://dx.doi.org/10.1016/j.ejphar.2009.08.022
37. Chartoumpekis DV, Palliyaguru DL, Wakabayashi N, Fazzari M, Khoo NKH, Schopfer FJ, et al. Nrf2 deletion from adipocytes, but not hepatocytes, potentiates systemic metabolic dysfunction after long-term high-fat diet-induced obesity in mice. Am J Physiol Endocrinol Metab. 2018;315(2):E180-e195. Http://dx.doi.org/10.1152/ajpendo.00311.2017
38. Kim YR, Lee EJ, Shin KO, Kim MH, Pewzner-Jung Y, Lee YM, et al. Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases. Exp Mol Med. 2019;51(11):1-16. Http://dx.doi.org/10.1038/s12276-019-0340-1
39. Sun X, Li X, Jia H, Wang H, Shui G, Qin Y, et al. Nuclear Factor E2-Related Factor 2 Mediates Oxidative Stress-Induced Lipid Accumulation in Adipocytes by Increasing Adipogenesis and Decreasing Lipolysis. Antioxid Redox Signal. 2020;32(3):173-192. Http://dx.doi.org/10.1089/ars.2019.7769
40. Tanaka S, Hikita H, Tatsumi T, Sakamori R, Nozaki Y, Sakane S, et al. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology. 2016;64(6):1994-2014. Http://dx.doi.org/10.1002/hep.28820
41. Kim YS, Nam HJ, Han CY, Joo MS, Jang K, Jun DW, et al. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation. Hepatology. 2021;73(4):1307-1326. Http://dx.doi.org/10.1002/hep.31423
42. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131-1135. Http://dx.doi.org/10.1038/nature07976
43. Arab JP, Arrese M, and Trauner M. Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. Annu Rev Pathol. 2018;13:321-350. Http://dx.doi.org/10.1146/annurev-pathol-020117-043617
44. Wang J, Liu Z, Hu T, Han L, Yu S, Yao Y, et al. Nrf2 promotes progression of non-small cell lung cancer through activating autophagy. Cell Cycle. 2017;16(11):1053-1062. Http://dx.doi.org/10.1080/15384101.2017.1312224
45. Wang Y, Zhang J, Huang ZH, Huang XH, Zheng WB, Yin XF, et al. Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop. Cell Death Dis. 2017;8(6):e2876. Http://dx.doi.org/10.1038/cddis.2017.265
46. Huang DD, Yan XL, Fan SD, Chen XY, Yan JY, Dong QT, et al. Nrf2 deficiency promotes the increasing trend of autophagy during aging in skeletal muscle: a potential mechanism for the development of sarcopenia. Aging (Albany NY). 2020;12(7):5977-5991. Http://dx.doi.org/10.18632/aging.102990
47. Tang M, Ji C, Pallo S, Rahman I, and Johnson GVW. Nrf2 mediates the expression of BAG3 and autophagy cargo adaptor proteins and tau clearance in an age-dependent manner. Neurobiol Aging. 2018;63:128-139. Http://dx.doi.org/10.1016/j.neurobiolaging.2017.12.001
48. Kitaoka Y, Takeda K, Tamura Y, Fujimaki S, Takemasa T, and Hatta H. Nrf2 deficiency does not affect denervation-induced alterations in mitochondrial fission and fusion proteins in skeletal muscle. Physiol Rep. 2016;4(24)Http://dx.doi.org/10.14814/phy2.13064
49. Saftig P, and Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. 2009;10(9):623-635. Http://dx.doi.org/10.1038/nrm2745
50. Tang JX, Li J, Cheng JM, Hu B, Sun TC, Li XY, et al. Requirement for CCNB1 in mouse spermatogenesis. Cell Death Dis. 2017;8(10):e3142. Http://dx.doi.org/10.1038/cddis.2017.555